↓ Skip to main content

Cochrane Database of Systematic Reviews

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma

Overview of attention for article published in Cochrane database of systematic reviews, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
3 tweeters
wikipedia
7 Wikipedia pages

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
160 Mendeley
Title
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
Published in
Cochrane database of systematic reviews, August 2012
DOI 10.1002/14651858.cd003915.pub4
Pubmed ID
Authors

Claire L Vale, Jayne Tierney, Sarah J Bull, Paul R Symonds

Abstract

Although endometrial adenocarcinoma is a common gynaecological cancer, a comparatively small proportion of patients present with, or develop, recurrent or advanced disease. However, for those women whose disease does progress or recur the prognosis is poor and the best treatment is yet to be identified. Co-morbidity, including obesity and cardiac disease, and concerns over toxicity have prevented more extensive studies of cytotoxic chemotherapy, although there are a number of active agents.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 158 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 18%
Researcher 23 14%
Student > Bachelor 15 9%
Other 14 9%
Unspecified 10 6%
Other 35 22%
Unknown 34 21%
Readers by discipline Count As %
Medicine and Dentistry 67 42%
Nursing and Health Professions 12 8%
Unspecified 10 6%
Biochemistry, Genetics and Molecular Biology 9 6%
Psychology 6 4%
Other 19 12%
Unknown 37 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2022.
All research outputs
#4,079,076
of 22,675,759 outputs
Outputs from Cochrane database of systematic reviews
#6,522
of 12,298 outputs
Outputs of similar age
#28,805
of 167,579 outputs
Outputs of similar age from Cochrane database of systematic reviews
#108
of 207 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,298 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,579 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 207 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.